HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 12265-12274

  Meng, Qingbing ^a   Zhao, Jie ^b   Liu, Hongbing ^a   Zhou, Guoyou ^a   Zhang, Wensheng ^a   Xu, Xingli ^a   Zheng, Minqian ^a  

^a Yancheng City No1 People's Hospital   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

HMGB1; Osteosarcoma; RNA interference

Indexed keywords

CASPASE 3; CYCLIN D1; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA;

ADULT; APOPTOSIS; ARTICLE; BONE CARCINOGENESIS; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; MALE; MG 63 CELL LINE; MTT ASSAY; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; ADOLESCENT; BONE TUMOR; CANCER STAGING; CELL CYCLE; CELL SURVIVAL; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; YOUNG ADULT;

ADOLESCENT; ADULT; APOPTOSIS; BONE NEOPLASMS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; OSTEOSARCOMA; RNA, MESSENGER; YOUNG ADULT;

EID: 84925285857     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2535-3     Document Type: Article

References (41)

1. Li R, Liu J, Wu H, Liu L, Wang L, Zhang S. TIKI2 suppresses growth of osteosarcoma by targeting Wnt/β-catenin pathway. Mol Cell Biochem. 2014;392:109–16.
2. PosthumaDeBoer J, Witlox MA, Kaspers GJ, van Royen BJ. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin Exp Metastasis. 2011;28:493–503.
3. Bielack SS, Carrle D, Hardes J, Schuck A, Paulussen M. Bone tumors in adolescents and young adults. Curr Treat Options Oncol. 2008;9:67–80.
4. Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125:229–34.
5. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115:1531–43.
6. He H, Ni J, Huang J. Molecular mechanisms of chemoresistance in osteosarcoma (review). Oncol Lett. 2014;7:1352–62.
7. Chiappetta C, Leopizzi M, Censi F, Puggioni C, Petrozza V, Rocca CD, et al. Correlation of the Rac1/Rhoa pathway with ezrin expression in osteosarcoma. Appl Immunohistochem Mol Morphol. 2014;22:162–70.
8. Hou CH, Lin FL, Tong KB, Hou SM, Liu JF. Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway. Biochem Pharmacol. 2014;89:453–63.
9. Shen A, Zhang Y, Yang H, Xu R, Huang G. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma. J Surg Oncol. 2012;105:830–4.
10. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, et al. Defining the epithelial stem cell niche in skin. Science. 2004;303:359–63.
11. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature. 2001;414:98–104.
12. Hu YH, Yang L, Zhang CG. HMGB1-a as potential target for therapy of hematological malignancies. Zhongguo shi yan xue ye xue za zhi. 2014;22:560–4.
13. Srinivasan M, Banerjee S, Palmer A, Zheng G, Chen A, Bosland MC, et al. HMGB1 in hormone-related cancer: a potential therapeutic target. Horm Cancer. 2014;5:127–39.
14. Yildirim M, Suren D, Demirpence O, Kaya V, Alikanoglu AS, Bulbuller N, et al. The role of high mobility group box 1 (HMGB1) in colorectal cancer. Med Sci Monit. 2014;20:530–7.
15. Xiao J, Ding Y, Huang J, Li Q, Liu Y, Ni W, et al. The association of HMGB1 gene with the prognosis of HCC. PLoS ONE. 2014;9:e89097.
16. Liu K, Huang J, Xie M, Yu Y, Zhu S, Kang R, et al. MIR34a regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell. Autophagy. 2014;10:442–52.
17. Jia L, Clear A, Liu FT, Matthews J, Uddin N, McCarthy A, et al. Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia. Blood. 2014;123:1709–19.
18. Weng H, Deng Y, Xie Y, Liu H, Gong F. Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors. BMC Cancer. 2013;13:311.
19. Moser B, Janik S, Schiefer AI, Mullauer L, Bekos C, Scharrer A, et al. Expression of rage and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology. PLoS ONE. 2014;9:e94118.
20. Zhang J, Kou YB, Zhu JS, Chen WX, Li S. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo. Int J Oncol. 2014;44:1268–76.
21. Srinivasan M, Banerjee S, Palmer A, Zheng G, Chen A, Bosland MC, et al. HMGB1 in hormone-related cancer: a potential therapeutic target. Horm Cancer. 2014;5(3):127–39.
22. Dong YD, Cui L, Peng CH, Cheng DF, Han BS, Huang F. Expression and clinical significance of HMGB1 in human liver cancer: knockdown inhibits tumor growth and metastasis in vitro and in vivo. Oncol Rep. 2013;29:87–94.
23. Liu Y, Xie CL, Qiu YZ, Tian YQ, Zhang X, Huang DH, et al. Expression of HMGB1 protein in laryngeal squamous cell carcinoma and its clinical significance. Zhonghua zhong liu za zhi. 2012;34:132–6.
24. Ko YB, Kim BR, Nam SL, Yang JB, Park SY, Rho SB. High-mobility group box 1 (HMGB1) protein regulates tumor-associated cell migration through the interaction with BTB domain. Cell Signal. 2014;26:777–83.
25. Chen J, Xi B, Zhao Y, Yu Y, Zhang J, Wang C. High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer. Gynecol Oncol. 2012;126:109–17.
26. Chen J, Liu X, Zhang J, Zhao Y. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference. J Cell Physiol. 2012;227:3629–38.
27. Yu Y, Xie M, Kang R, Livesey KM, Cao L, Tang D. HMGB1 is a therapeutic target for leukemia. Am J Blood Res. 2012;2:36–43.
28. Monga SP. Role and regulation of β-catenin signaling during physiological liver growth. Gene Expr. 2014;16:51–62.
29. Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2008;414:13–21.
30. Xu YB, Du QH, Zhang MY, Yun P, He CY. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci. 2013;17:2486–94.
31. Cock-Rada AM, Medjkane S, Janski N, Yousfi N, Perichon M, Chaussepied M, et al. SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9. Cancer Res. 2012;72:810–20.
32. Zwaga T, Bovee JV, Kroon HM. Osteosarcoma of the femur with skip, lymph node, and lung metastases. Radiographics. 2008;28:277–83.
33. Gatla HR, Singha B, Persaud V, Vancurova I. Evaluating cytoplasmic and nuclear levels of inflammatory cytokines in cancer cells by Western blotting. Methods Mol Biol. 2014;1172:271–83.
34. Zhang P, Liu Y, Wu ZH, Chen J, Chen G, Zhou QH. Effects of high mobility group box-1 silencing upon the invasion and proliferation in human lung cancer cell L9981 by RNA inhibition. Zhonghua yi xue za zhi. 2009;89:3156–9.
35. Yin Y, Li W, Deng M, Zhang P, Shen Q, Wang G, et al. Extracellular high mobility group box chromosomal protein 1 promotes drug resistance by increasing the expression of P-glycoprotein expression in gastric adenocarcinoma cells. Mol Med Rep. 2014;9:1439–43.
36. Song B, Song WG, Li ZJ, Xu ZF, Wang XW, Wang CX, et al. Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. Cell Biochem Funct. 2011. doi: 10.1002/cbf.1811.
37. Gnanasekar M, Thirugnanam S, Ramaswamy K. Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMBG1) expression leads to inhibition of prostate cancer cell survival and apoptosis. Int J Oncol. 2009;34:425–31.
38. Yu Y, Xie M, He YL, Xu WQ, Zhu S, Cao LZ. Role of high mobility group box 1 in adriamycin-induced apoptosis in leukemia K562 cells. Ai zheng. 2008;27:929–33.
39. Suren D, Yildirim M, Demirpence O, Kaya V, Alikanoglu AS, Bulbuller N, et al. The role of high mobility group box 1 (HMGB1) in colorectal cancer. Med Sci Monit. 2014;20:530–7.
40. Chen RC, Yi PP, Zhou RR, Xiao MF, Huang ZB, Tang DL, et al. The role of HMGB1-rage axis in migration and invasion of hepatocellular carcinoma cell lines. Mol Cell Biochem. 2014;390:271–80.
41. Li ZJ, Song B, Liu J, Han JJ, Wang CX, Zhu YX, et al. Inhibitory effect of silencing of HMGB1 gene expression on the invasive and metastatic abilities of MGC-803 gastric cancer cells. Zhonghua zhong liu za zhi. 2013;35:244–8.